TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27989618

Group type: EXPERIMENTAL
Intervention: 45-mg sustained-release pelubiprofen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: trans-alcohol pelubiprofen (major active metabolite)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 75-mg sustained-release eperisone hydrochloride
Number of subjects: 24
Study: 26390073

Group type: EXPERIMENTAL
Intervention: Active Auricular Point Acupressure (APA), n = 16
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control Auricular Point Acupressure (sham treatment), n = 15
Number of subjects: 31
Study: 25552113

Group type: EXPERIMENTAL
Intervention: Prolonged flow-aspiration drainage of laparotomy wounds
Number of subjects: 254

Group type: COMPARATOR
Intervention: Conventional method (in layers, tightly)
Number of subjects: 254
Study: 23107083

Group type: EXPERIMENTAL
Intervention: Pregnancy options counseling workshop
Number of subjects: 105

Group type: COMPARATOR
Intervention: Preworkshop group (control)
Number of subjects: 105
Study: 19544815

Group type: EXPERIMENTAL
Intervention: Reduced excursive occlusal contacts on one tooth using a fine grain diamond bur.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non‐adjusted teeth (control group).
Number of subjects: 39
Study: 17460608

Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Torsemide
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: NCC alanine 264 allele (Gly264Ala)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Variant alleles of rs5,723 (Leu649Leu) and rs5,729 in SCNN1G
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Extended haplotype homozygosity of NCC alanine 264 allele
Number of subjects: 97
Study: 14760121

Group type: EXPERIMENTAL
Intervention: MOPP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 100

Group type: COMPARATOR
Intervention: MOPP and ABVD
Number of subjects: 100
Study: 11473882

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (238 +/- 50 microg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous sufentanil (160 +/- 32 microg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Epidural and IV sufentanil)
Number of subjects: 20
Study: 9533424

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Short-acting nifedipine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Slow-releasing nifedipine
Number of subjects: 45
Study: 8037104

Group type: EXPERIMENTAL
Intervention: Enalapril, 2.5 mg twice per day for 7 days (mean 6.1, range 2 to 7, median 7)
Number of subjects: 7487

Group type: EXPERIMENTAL
Intervention: Enalapril, 2.5 mg twice per day
Number of subjects: 7487
Study: 2928734

Group type: EXPERIMENTAL
Intervention: Horizontal gastroplasty (HGP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty (VBGP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (diet alone)
Number of subjects: 45
Study: 29703051

Group type: EXPERIMENTAL
Intervention: 10% HES (130/0.42)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 6% HES (130/0.42)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Crystalloid
Number of subjects: 63
Study: 29214999

Group type: EXPERIMENTAL
Intervention: Engineered KGSADH variants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wild-type KGSADH
Number of subjects: 0
Study: 26305869

Group type: EXPERIMENTAL
Intervention: Text-message intervention to promote alertness
Number of subjects: 100
Study: 23154155

Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) meal providing 2g/kg BM of carbohydrate
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low Glycemic Index (LGI) meal providing 2g/kg BM of carbohydrate
Number of subjects: 7
Study: 21542026

Group type: EXPERIMENTAL
Intervention: 0.4 g/kg alcohol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 40
Study: 18438229

Group type: EXPERIMENTAL
Intervention: Plyometric exercises including two‐foot ankle hops, 15‐cm cone hops, tuck, pike, box jumps, one‐ and two‐leg vertical jump and reach, squat jumps with approximately 30% of their 1RM squat load, and 30‐ and 61‐cm depth jumps.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Plyometric exercises (specific exercises not detailed)
Number of subjects: 23
Study: 17090988

Group type: EXPERIMENTAL
Intervention: Yakson therapy (5 minutes of hand laying on the back and caressing the abdomen)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Yakson therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 12576164

Group type: EXPERIMENTAL
Intervention: 3.0 mg/kg/min infusion of valproate sodium injection
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg/min infusion of valproate sodium injection
Number of subjects: 112
Study: 10551687

Group type: EXPERIMENTAL
Intervention: Abciximab plus low-dose heparin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard-dose heparin
Number of subjects: 100
Study: 8913487

Group type: EXPERIMENTAL
Intervention: Atevirdine 600 mg three times a day for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1991610

Group type: EXPERIMENTAL
Intervention: Computed Radiography (CR) using imaging plate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional screen/film system
Number of subjects: 0
Study: 6193346

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Piretanide (PT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31911605

Group type: EXPERIMENTAL
Intervention: Two-sample multivariable Mendelian randomization based on Bayesian model averaging (MR-BMA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of publicly-available summarized data on metabolites
Number of subjects: 0
Study: 29880491

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg daily)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg every 2 weeks)
Number of subjects: 80
Study: 28079755

Group type: EXPERIMENTAL
Intervention: 10 mg zeaxanthin per day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 20 mg zeaxanthin per day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 8
Study: 26366802

Group type: EXPERIMENTAL
Intervention: Aspirin desensitization (AD)
Number of subjects: 16
Study: 23478167

Group type: EXPERIMENTAL
Intervention: Active RPSS with daily motor training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham RPSS with daily motor training
Number of subjects: 20
Study: 21501665

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation training (MM) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18199731

Group type: EXPERIMENTAL
Intervention: High IGF‐I/IGFBP‐3 ratio
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: IGFBP‐3
Number of subjects: 137
Study: 17156423

Group type: EXPERIMENTAL
Intervention: Physical exercise (one-hour supervised session twice a week and daily home exercises)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standardised rest
Number of subjects: 58
Study: 14660201

Group type: EXPERIMENTAL
Intervention: JTMT with the right hand (R)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JTMT with the left hand (L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirror version of JTMT with the left hand (M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Part A (first examination)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Part A (second and third performances)
Number of subjects: 0
Study: 10834413

Group type: EXPERIMENTAL
Intervention: Insulin aspart (IAsp)
Number of subjects: 882

Group type: COMPARATOR
Intervention: Regular human insulin (HI)
Number of subjects: 882

Group type: EXPERIMENTAL
Intervention: Insulin aspart (IAsp) and Regular human insulin (HI)
Number of subjects: 882
Study: 9357345

Group type: EXPERIMENTAL
Intervention: 6-month relapse prevention program
Number of subjects: 539

Group type: COMPARATOR
Intervention: Therapeutic community program
Number of subjects: 539

Group type: COMPARATOR
Intervention: 12-month therapeutic community program
Number of subjects: 539

Group type: COMPARATOR
Intervention: 6-month therapeutic community program
Number of subjects: 539

Group type: COMPARATOR
Intervention: 3-month relapse prevention program
Number of subjects: 539
Study: 7934683

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isoflurane anaesthesia
Number of subjects: 20
Study: 3533134

Group type: EXPERIMENTAL
Intervention: Nifedipine (oral administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritodrine (intravenous administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 31335871

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet
Number of subjects: 1252

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1252
Study: 29976161

Group type: EXPERIMENTAL
Intervention: Serial IV bolus (6 g loading dose with 2 g bolus every 2 h using a Springfusor® pump)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Continuous infusion (4 g loading dose with 1 g/hr. continuous infusion)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serial IV bolus
Number of subjects: 200

Group type: COMPARATOR
Intervention: Continuous infusion
Number of subjects: 200
Study: 26882922

Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg × 3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Flurbiprofen (50 mg × 3)
Number of subjects: 40
Study: 24253285

Group type: EXPERIMENTAL
Intervention: Norwalk virus (various dosages)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Norwalk virus (dosage for secretor-positive blood group O or A)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Norwalk virus (dosage for all secretor-positive persons)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Norwalk virus
Number of subjects: 57
Study: 23875569

Group type: EXPERIMENTAL
Intervention: Odor-object identity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Odor valence and edibility decision response times
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low road and high road processing
Number of subjects: 0
Study: 20533760

Group type: EXPERIMENTAL
Intervention: Benzocaine lozenges (8 mg), n = 123
Number of subjects: 246

Group type: COMPARATOR
Intervention: Commercial pastilles (8 mg), n = 123
Number of subjects: 246
Study: 18259029

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 4963

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 4963
Study: 16840654

Group type: EXPERIMENTAL
Intervention: Exercise challenge
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bronchodilator administration
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline measurements in subjects with EIB
Number of subjects: 18
Study: 12568852

Group type: EXPERIMENTAL
Intervention: IL‐1beta stimulation of cultured stromal cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recombinant IL‐1 receptor antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anti‐IL‐1beta antibody
Number of subjects: 0
Study: 10867375

Group type: EXPERIMENTAL
Intervention: Immunotherapy with specific allergens (subcutaneous administration of the vaccine)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 105
Study: 8623949

Group type: EXPERIMENTAL
Intervention: Large-dose fentanyl anesthesia (LDFA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Small-dose fentanyl anesthesia (SDFA)
Number of subjects: 40
Study: 1423201

Group type: EXPERIMENTAL
Intervention: CYADIC (cyclophosphamide, doxorubicin, and dacarbazine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CYVADIC (vincristine added to CYADIC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cumulative dose of cyclophosphamide < 7.5 g/m2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cumulative dose of cyclophosphamide > 7.5 g/m2
Number of subjects: 0
Study: 3804185

Group type: EXPERIMENTAL
Intervention: Omeprazole 5 mg daily
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29945562

Group type: EXPERIMENTAL
Intervention: nal‐IRI + 5‐FU/LV
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: nab‐P + Gem followed by nal‐IRI + 5‐FU/LV
Number of subjects: 56
Study: 27776761

Group type: EXPERIMENTAL
Intervention: Intraoperative low-frequency electroacupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no electroacupuncture)
Number of subjects: 0
Study: 25700144

Group type: EXPERIMENTAL
Intervention: Computer-delivered intervention (electronic educational and decision support tools)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study: 21753734

Group type: EXPERIMENTAL
Intervention: Collagen sponge and xenogeneic bone grafts
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no special treatments for the extraction socket)
Number of subjects: 20
Study: 16219019

Group type: EXPERIMENTAL
Intervention: IGT(fast) group
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IGT(slow) group
Number of subjects: 22
Study: 12089651

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 0
Study: 9684190

Group type: EXPERIMENTAL
Intervention: Sublingual birch pollen extract
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 7979841

Group type: EXPERIMENTAL
Intervention: 20 mg fluvastatin sodium once daily
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: 10 mg fluvastatin sodium twice daily
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 2661389

Group type: EXPERIMENTAL
Intervention: 200 mg metoprolol per day
Number of subjects: 38

Group type: COMPARATOR
Intervention: 25 mg hydrochlorothiazide
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Comparison of responders and non-responders within metoprolol group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comparison of responders and non-responders within hydrochlorothiazide group
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hormonal analyses
Number of subjects: 38
Study: 1182489

Group type: EXPERIMENTAL
Intervention: Verbal test (Miller Analogy Test) with motivation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spatial test (Street) with motivation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Verbal test (Miller Analogy Test) without motivation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spatial test (Street) without motivation
Number of subjects: 24
Study: 12208924

Group type: EXPERIMENTAL
Intervention: Epoch stem (porous-coated composite stem with reduced stiffness)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Anatomic stem (stiff stem with a porous coating)
Number of subjects: 68
Study: 31631177

Group type: EXPERIMENTAL
Intervention: Ambulatory laparoscopic cholecystectomy (ALC)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Usual laparoscopic cholecystectomy (ULC)
Number of subjects: 71
Study: 29054679

Group type: EXPERIMENTAL
Intervention: Conventional method using a custom tray border moulded with impression compound and silicone
Number of subjects: 27

Group type: COMPARATOR
Intervention: Simplified method using a stock tray and alginate
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 27
Study: 27261067

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine
Number of subjects: 4193

Group type: COMPARATOR
Intervention: Quadrivalent meningococcal vaccine
Number of subjects: 4193
Study: 24752177

Group type: EXPERIMENTAL
Intervention: efavirenz/lamivudine/zidovudine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: efavirenz/emtricitabine/tenofovir-DF
Number of subjects: 270

Group type: COMPARATOR
Intervention: atazanavir/emtricitabine/didanosine-EC
Number of subjects: 270
Study: 22297667

Group type: EXPERIMENTAL
Intervention: Better Care system with IEE score cutoff point set at 42%
Number of subjects: 8

Group type: COMPARATOR
Intervention: Better Care system compared with electrical activity of the diaphragm (EAdi)
Number of subjects: 8
Study: 20461767

Group type: EXPERIMENTAL
Intervention: Fibrin glue spray applied to the axillary fossa plus placement of closed suction drainage
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placement of closed suction drainage only
Number of subjects: 159
Study: 18991123

Group type: EXPERIMENTAL
Intervention: Citalopram treatment with remission of maternal depression
Number of subjects: 114
Study: 16148999

Group type: EXPERIMENTAL
Intervention: Medical adhesive products applied to retroperitoneal regions (Group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 70
Study: 12195637

Group type: EXPERIMENTAL
Intervention: Health promotion plus occupational health and safety intervention (HP/OHS)
Number of subjects: 9019

Group type: COMPARATOR
Intervention: Health promotion (HP)
Number of subjects: 9019
Study: 9485226

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 20 ppm (n = 6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nitrogen (n = 5)
Number of subjects: 11
Study: 7649143

Group type: EXPERIMENTAL
Intervention: Four-pack cool vest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Six-pack cool vest
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no cool vest)
Number of subjects: 12
Study: 2801583

Group type: EXPERIMENTAL
Intervention: Soy protein diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: Casein diet
Number of subjects: 11
Study: 418546

Group type: EXPERIMENTAL
Intervention: Trifluorothymidine (TFT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Idoxuridine (IDU)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both IDU and TFT
Number of subjects: 33
Study: 31268469

Group type: EXPERIMENTAL
Intervention: High-intensity interval endurance training (3 times a week for 45 minutes)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Resistance training (3 times a week for 45 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 50
Study: 28584189

Group type: EXPERIMENTAL
Intervention: Motivational counselling and SMS reminders (3 sessions over 16 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Motivational counselling and SMS reminders
Number of subjects: 150
Study: 25734525

Group type: EXPERIMENTAL
Intervention: Verbal working memory training for 8 weeks
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Reading training for 8 weeks
Number of subjects: 4
Study: 23902482

Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation
Number of subjects: 400

Group type: COMPARATOR
Intervention: Nonprotective ventilation
Number of subjects: 400
Study: 21798883

Group type: EXPERIMENTAL
Intervention: Sifalimumab (0.3, 1, 3, 10 or 30 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19341576

Group type: EXPERIMENTAL
Intervention: Silver diammine fluoride (SDF)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cross tooth‐brushing technique (CTT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Glass ionomer fissure sealant (GIC)
Number of subjects: 66
Study: 16868501

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 514

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 514
Study: 14726777

Group type: EXPERIMENTAL
Intervention: Tailored training with a booster after 30 days
Number of subjects: 1325

Group type: EXPERIMENTAL
Intervention: Tailored training with boosters at 30 and 90 days
Number of subjects: 1325

Group type: EXPERIMENTAL
Intervention: Nontailored predictor-based training with boosters
Number of subjects: 1325

Group type: COMPARATOR
Intervention: Control group (no boosters)
Number of subjects: 1325
Study: 11737409

Group type: EXPERIMENTAL
Intervention: p24‐VLP 500 microg
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: p24‐VLP 1000 microg
Number of subjects: 304

Group type: COMPARATOR
Intervention: alum placebo
Number of subjects: 304
Study: 9403144

Group type: EXPERIMENTAL
Intervention: Dependent women
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Self-critical women
Number of subjects: 80
Study: 8433832

Group type: EXPERIMENTAL
Intervention: Intermittent monitoring
Number of subjects: 169

Group type: COMPARATOR
Intervention: Continuous monitoring
Number of subjects: 169
Study: 3618273

Group type: EXPERIMENTAL
Intervention: Rolipram
Number of subjects: 21

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 21
Study: 29081219

Group type: EXPERIMENTAL
Intervention: mPLN > 3
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Lymphovascular invasion (LVI)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Non-squamous cell carcinoma (non-SqCC)
Number of subjects: 249

Group type: COMPARATOR
Intervention: mPLN ≤ 3
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Scoring system using mPLNs > 3, LVI, and non-SqCC
Number of subjects: 249
Study: 27369028

Group type: EXPERIMENTAL
Intervention: Online learning module on FPDR
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no online learning)
Number of subjects: 74
Study: 25179088

Group type: EXPERIMENTAL
Intervention: Mouthwash solution containing lysine (0.4%) and glycerol monolaurate (0.2%) (LGM)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Traditional treatment for gastric eradication
Number of subjects: 277

Group type: COMPARATOR
Intervention: Traditional drug gastric eradication and teeth cleaning (TC)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Treatment of oral infection
Number of subjects: 277
Study: 22437920

Group type: EXPERIMENTAL
Intervention: Ethanol ablation (EA)
Number of subjects: 217
Study: 19944517

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 18155448

Group type: EXPERIMENTAL
Intervention: Metabolic stressor (2DG)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia
Number of subjects: 44
Study: 15329742

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34